AMGEN Inc.

NASDAQ:AMGN  
227.57
-1.33 (-0.58%)
4:00:02 PM EDT: $227.72 +0.15 (+0.07%)
Products

FDA Approves New Kyprolis Combination Regimen With Darzalex Faspro And Dexamethasone

Published: 12/01/2021 18:41 GMT
AMGEN Inc. (AMGN) - FDA Approves New Kyprolis® (carfilzomib) Combination Regimen With Darzalex Faspro® (daratumumab and Hyaluronidase-fihj) and Dexamethasone for Patients With Multiple Myeloma at First Or Subsequent Relapse.